Targeting cPLA₂ derived lipid hydroperoxides as a potential intervention for sarcopenia

Area of Science:

• Muscle physiology and aging research
• Oxidative stress and cellular signaling
• Neurodegenerative disease mechanisms

Background:

• Neuromuscular junction defects contribute to sarcopenia, the age-related loss of muscle.
• Denervation leads to increased mitochondrial hydrogen peroxide (H2O2) and lipid hydroperoxides (LOOHs) in muscles.
• The specific pathways driving neurogenic muscle atrophy remain incompletely understood.

Purpose of the Study:

• To determine the distinct roles of mitochondrial H2O2 and cytosolic phospholipase A2 (cPLA2)-derived LOOHs in neurogenic muscle atrophy.
• To investigate the contribution of arachidonic acid metabolism to muscle loss following denervation.

Main Methods:

• Comparing the effects of denervation on mitochondrial H2O2 and cPLA2 pathway activity in muscle.
• Utilizing in vivo inhibition of cPLA2 to assess its role in muscle atrophy.
• Measuring muscle fiber size, oxidative damage, and hydroperoxide levels.

Main Results:

• Denervation elevated cPLA2 protein, activity, and downstream LOOHs, but not mitochondrial H2O2.
• Enhanced scavenging of mitochondrial H2O2 did not prevent denervation-induced muscle atrophy.
• Inhibiting cPLA2 reduced LOOH production, mitigated muscle atrophy, preserved fiber size, and decreased oxidative damage.

Conclusions:

• Cytosolic phospholipase A2 (cPLA2)-mediated lipid hydroperoxide (LOOH) generation is a key driver of neurogenic muscle atrophy, including age-related sarcopenia.
• Mitochondrial electron transport chain-derived H2O2 is not the primary mediator of denervation-induced muscle loss.
• Targeting the cPLA2 pathway offers a potential therapeutic strategy for combating muscle wasting conditions.